You are here
The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.
SBC: Zymeron Corporation Topic: CBD181004
Nerve agents exert their toxic effect by binding to and inactivating enzyme acetylcholinesterase, a key enzymatic regulator of cholinergic neurotransmission. The binding becomes irreversible after a varying amount of time with nerve agents and this aging process limits the treatment window of oxime reactivators. To enhance the current antidote treatment of nerve agent autoinjectors, a pyridostigmi ...SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense
SBC: Corvid Technologies LLC Topic: SOCOM061008
At present, there are no solutions for equipping Class 1 and 2 unmanned aerial system (UAS) platforms with weapons systems that provide the capability for opportunistic engagement of high value targets (HVT). Munitions deployed on larger UAS, and other fixed-wing SOCOM assets, greatly exceed the payload capacity of Class 1 and 2 UAS assets currently in use for intelligence, surveillance, and recon ...SBIR Phase II 2019 Department of DefenseSpecial Operations Command
SBC: MANNING APPLIED TECHNOLOGY Topic: CBD05112
Manning Applied Technology proposes development of the MP-100 handheld FT-infrared photoacoustic chemical agent detector, following a highly successful Phase I effort. Chemical attacks and accidents can be mitigated partially by cost-effective sensors. High priority programs will benefit from a sensor compliant to Joint Warning & Reporting Network (JWARN) standards. The device is ideally suited to ...SBIR Phase II 2006 Department of DefenseOffice for Chemical and Biological Defense